Rubella vaccines: past, present and future (Q36505679)

14 August 2017

1 reference

title

Rubella vaccines: past, present and future (English)

1 reference

14 August 2017

1 reference

Best JM

1

1 reference

14 August 2017

1 August 1991

1 reference

Epidemiology and Infection

14 August 2017

1 reference

14 August 2017

107

1 reference

14 August 2017

1

1 reference

14 August 2017

17-30

1 reference

Rubella-specific immune complexes after congenital infection and vaccination

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella vaccination: persistence of antibodies for up to 16 years

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Persistence of rubella antibody 8-18 years after vaccination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

The immunoglobulin M response to rubella vaccine in young adult women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Vaccination of adults with Wistar RA 27/3 rubella vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Prospects for a rubella virus vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Review of studies with inactivated rubella virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Polyneuropathy following rubella immunization. A follow-up study and review of the problem

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella Vaccination and Thrombocytopenia††

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella-associated arthritis. II. Relationship between circulating immune complex levels and joint manifestations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Serological evaluation of a measles, mumps, and rubella vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Fetal infection after maternal reinfection with rubella: criteria for defining reinfection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Congenital rubella after previous maternal immunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Development of attenuated rubella virus vaccines in Japan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Oligomeric immunoglobulin A antibody response to rubella virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

HLA antigens and responses to rubella vaccination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

The ten year follow-up of the persistence of humoral antibody to rubella virus acquired by vaccination with the Japanese To-336 vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Viremia, Virus Excretion, and Antibody Responses after Challenge in Volunteers with Low Levels of Antibody to Rubella Virus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella Virus Wild-type and RA27/3 Strains: A Comparison by Polyacrylamide-gel Electrophoresis and Radioimmune Precipitation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Persistent rubella infection and rubella-associated arthritis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Vaccination of women with the Cendehill strain of rubella virus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella infection of synovial cells and the resistance of cells derived from patients with rheumatoid arthritis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Trials of intranasally administered rubella vaccine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Attenuation ob rubella virus by serial passage in primary rabbit kidney cell cultures. I. Growth characteristics in vitro and production of experimental vaccines at different passage levels

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Attenuated rubella virus. I. Development and laboratory characterization

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Experimental rubella virus infection in the rhesus monkey

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Intermittent arthritis following rubella vaccination. A three-year follow-up.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Cell-mediated immune response following natural rubella and rubella vaccination

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

New Japanese Rubella Vaccine: Comparative Trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Persistent rubella virus infection associated with chronic arthritis in children

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Persistent rubella virus infection of human synovial cells cultured in vitro

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Effect of low level immunity on response to live rubella virus vaccine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Rubella virus cDNA. Sequence and expression of E1 envelope protein

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Baculovirus polyhedrin promoter-directed expression of rubella virus envelope glycoproteins, E1 and E2, in Spodoptera frugiperda cells

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Expression of rubella virus cDNA encoding the E1 structural protein

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Localization of the rubella E1 epitopes

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Influence of Age on Clinical Response to HPV-77 Duck Rubella Vaccine

28 June 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268800048640

The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268800048640

Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268800048640

Recovery of rubella virus from army recruits.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Cell-mediated immune response in rubella infections.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2272034

Recurrent joint symptoms in children vaccinated with HPV-77DK12 rubella vaccine

21 September 2018

1 reference

12 December 2020

Arthritis associated with induced rubella infection

1 reference

12 December 2020

Joint symptoms, immune complexes, and rubella

1 reference

12 December 2020

Serological response to rubella revaccination

1 reference

12 December 2020

A bio-engineered rubella E1 antigen

1 reference

12 December 2020

Immune responses to wild and vaccine rubella viruses after rubella vaccination

1 reference

12 December 2020

Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy

1 reference

12 December 2020

Rubella vaccination: persistence of antibodies for 10-21 years

1 reference

12 December 2020

Comparison of various serological methods and diagnostic kits for the detection of acute, recent, and previous rubella infection, vaccination, and congenital infections

1 reference

12 December 2020

Specific IgM responses after rubella vaccination; potential application following inadvertent vaccination during pregnancy

1 reference

12 December 2020

Serologic response to revaccination with two rubella vaccines

1 reference

12 December 2020

[Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination]

1 reference

12 December 2020

Prevalence of rubella antibodies in Massachusetts schoolchildren

1 reference

12 December 2020

1 reference

12 December 2020

Persistence of vaccine-induced immune responses to rubella: comparison with natural infection

1 reference

12 December 2020

Persistence of rubella antibodies after vaccination: detection after experimental challenge

1 reference

12 December 2020

Challenge with rubella virus after loss of detectable vaccine-induced antibody

1 reference

https://api.crossref.org/works/10.1017%2FS0950268800048640

7 January 2021

inferred from DOI database lookup

Duration of immunity after rubella vaccination: a long-term study in Switzerland

1 reference

https://api.crossref.org/works/10.1017%2FS0950268800048640

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1017/S0950268800048640

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

2272034